CCS Research Awards
Sponsored by the BMS-Pfizer alliance, the AF (Atrial Fibrillation) Research Awards support excellence in AF research and support promising Canadian early career researchers with an interest in AF.
Application deadline extended: Monday, April 12, 2021 at 11:59 p.m. EST
CCS/Pfizer ATTR-CM Research Fellowship Award
This is a salary award where the purpose is to foster the growth of peer-reviewed Canadian research in the area of Transthyretin Amyloid Cardiomyopathy (ATTR-CM), with a focus on excellence and support for early career Canadian researchers familiar with diagnosing and treating patients with ATTR-CM who are looking to establish an independent research career.
Application deadline extended: Monday, April 12, 2021 at 11:59 p.m. EST
CCS-Bayer Cardiovascular Research Award
The CCS − Bayer Cardiovascular Research Award is open to Canadian clinical trainees (PGY 4-6) undertaking a research project on any topic related to thrombosis, anticoagulation, stroke, heart failure or atrial fibrillation — particularly research that has the potential to advance knowledge about or improve the care of patients at risk for vascular, thrombotic or embolic events.
Application deadline: Wednesday, August 11th, 2021 at 12:00 pm (EST)
CCS/HSRLCE/BI-Lilly Cardiometabolic Research Award
The Canadian Cardiovascular Society (CCS), Heart & Stroke / Richard Lewar Centre of Excellence in Cardiovascular Research (HSRLCE), and the BI-Lilly Alliance are proud to support the 2021 CCS/HSRLCE/BI-Lilly Cardiometabolic Research Award. This award is intended for trainees, residents and early career members for a research project on any topic related to cardiometabolic disease.
Applications deadline: Wednesday, August 11th, 2021 at 11:59 AM EST
CCS COVID-19 Challenge for Canada Initiative (CCS-C3I)
As the prevalence and outcomes of cardiovascular complications of COVID-19 remain poorly understood and uncharacterized, the aim of C3I is to empower the CCS clinician-scientist community to be prepared to harness emerging large-scale funds. By fostering multisite cardiovascular research across Canada, our CV community will be at the forefront of readiness for large-scale, CVD-related COVID-19 disease initiatives.
Application deadline: TBD